Dreyling, Martin,Heinrich, Daniel Alexander,Herting, Frank,Klein, Christian
申请号：
AU2010281867
公开号：
AU2010281867A1
申请日:
2010.08.12
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody with fludarabine and/or mitoxantrone.
